Table 2.
Summary of advantages of PDA core@shell nanoparticles with various cores.
| Types of the core | Representative nanoparticles | Advantages of PDA modification | Ref. |
|---|---|---|---|
| Metal core | Au@PDA | Direct the growth of Au nanopetals Surface passivation Photothermal stability Improve the biocompatibility |
[41,45,46] |
| Fe2O3@PDA Fe3O4@PDA | Anchor bioactive molecules Secondary modification Photothermal conversion |
[52,53] | |
| TiO2 NT@PDA | Improve the biocompatibility Enhance drug loading efficiency |
[59,60] | |
| Mn3O4@PDA MnCO3@PDA | Improve the relaxation rate Enhance drug loading efficiency |
[[62], [63], [64], [65]] | |
| ZnO@PDA | Improve the biocompatibility | [67,68] | |
| Nonmetal core | MSN@PDA | pH-responsive “gate keeper” | [42,72,73] |
| RGO@PDA | Improve conductivity Enhance bioactivity |
[44,78] | |
| HAp@PDA | Improve biocompatibility Enhance bioactivity |
[81,82] | |
| Organic core | PLGA@PDA | Improve biocompatibility Enhance hydrophilicity |
[83] |
| BSA@PDA | Enhance drug loading efficiency | [94] | |
| MOF core | MIL-100@PDA ZIF-8@PDA |
Improve the biocompatibility Tune the biodegradability |
[[88], [89], [90]] |
| Drug self-assembly core | DOX@PDA PTX@Au@PDA/DOX TIIA@PDA |
Prolong the blood circulation time pH-responsive “gate keeper” | [[91], [92], [93]] |